NEW

Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Olympus Supports Safety Actions Regarding Surgical Smoke

Olympus has announced its support of The Joint Commission’s recommended safety actions for managing the hazards of exposure to surgical smoke for health care staff in operating rooms.

Exofin Fusion Redesign Receives FDA Approval

Chemence Medical, a leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion skin closure system.

Nihon Kohden Introduces New Bedside Monitor

nihon-bsm-3562Nihon Kohden has launched its BSM-3500, the latest advancement in its line of bedside monitors. Designed to meet the precise needs of ambulatory surgery and specialty centers, the BSM-3500 comes fully optimized with all features – both premium and standard – ready to use at a moment’s notice, bringing among the highest standards of care to low acuity settings.

“Hospitals and health systems know that not every patient requires intensive care or use of a high-acuity bed, but they also know patients in low-acuity areas still need to be monitored, no matter how minor a procedure may seem,” said Dr. Wilson P. Constantine, CEO of Nihon Kohden America. “By using Nihon Kohden’s line of quality, reliable monitors that are developed with our premium-as-standard philosophy, health care providers know their patients will be taken care of, no matter where they are in a health system.”

In addition to a range of standard monitoring features, the BSM-3500 offers a number of capabilities to ensure care in low acuity settings. These include the ability to spot real-time mini trends for early detection of vital sign variability during outpatient procedures. In addition, the new monitor works with Nihon Kohden’s proprietary cap-ONE Mainstream CO2 Sensor Kit, which is the world’s first wearable mainstream CO2 sensor for non-intubated patients. As with all Nihon Kohden monitoring systems, the BSM-3500 is also designed to seamlessly integrate with electronic medical records systems. 

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X